Third Harmonic Bio logo

Third Harmonic BioNASDAQ: THRD

Profile

Sector:

Healthcare

Industry:

Biotechnology

Country:

United States

IPO:

14 September 2022

Next earnings report:

26 March 2025

Last dividends:

N/A

Next dividends:

N/A
$523.58 M
-44%vs. 3y high
67%vs. sector
-vs. 3y high
-vs. sector
-43%vs. 3y high
53%vs. sector
-vs. 3y high
-vs. sector

Price

after hours | Wed, 20 Nov 2024 21:20:00 GMT
$11.62-$0.84(-6.74%)

Dividend

No data over the past 3 years
No data over the past 3 years

Analysts recommendations

Institutional Ownership

THRD Latest News

Wall Street Analysts Believe Third Harmonic Bio, Inc. (THRD) Could Rally 26.67%: Here's is How to Trade
zacks.com11 November 2024 Sentiment: POSITIVE

The average of price targets set by Wall Street analysts indicates a potential upside of 26.7% in Third Harmonic Bio, Inc. (THRD). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.

Third Harmonic Bio to Participate in the Morgan Stanley Global Healthcare Conference
GlobeNewsWire31 August 2023 Sentiment: POSITIVE

SAN FRANCISCO, Aug. 31, 2023 (GLOBE NEWSWIRE) -- Third Harmonic Bio, Inc. (Nasdaq: THRD), a biopharmaceutical company focused on advancing the next wave of medicine for inflammatory diseases, today announced that Chief Executive Officer Natalie Holles will participate in a fireside chat at the Morgan Stanley Global Healthcare Conference on Tuesday, September 12, 2023, from 7:30-7:55 a.m. ET.

What type of business is Third Harmonic Bio?

Third Harmonic Bio, Inc., a biopharmaceutical company, focuses on the development of the medicine for the treatment of dermal, respiratory, and gastrointestinal inflammatory diseases. The company develops oral small-molecule inhibitors of KIT, a cell surface receptor that serves as the master regulator of mast cell function and survival. It is also developing THB335, an oral small molecule KIT inhibitor for the treatment of mast cell-mediated skin, respiratory, and gastrointestinal conditions. The company was formerly known as Project IGE, Inc. and changed its name to Third Harmonic Bio, Inc. in June 2019. Third Harmonic Bio, Inc. was incorporated in 2019 and is headquartered in San Francisco, California.

What sector is Third Harmonic Bio in?

Third Harmonic Bio is in the Healthcare sector

What industry is Third Harmonic Bio in?

Third Harmonic Bio is in the Biotechnology industry

What country is Third Harmonic Bio from?

Third Harmonic Bio is headquartered in United States

When did Third Harmonic Bio go public?

Third Harmonic Bio initial public offering (IPO) was on 14 September 2022

What is Third Harmonic Bio website?

https://www.thirdharmonicbio.com

Is Third Harmonic Bio in the S&P 500?

No, Third Harmonic Bio is not included in the S&P 500 index

Is Third Harmonic Bio in the NASDAQ 100?

No, Third Harmonic Bio is not included in the NASDAQ 100 index

Is Third Harmonic Bio in the Dow Jones?

No, Third Harmonic Bio is not included in the Dow Jones index

When was Third Harmonic Bio the previous earnings report?

No data

When does Third Harmonic Bio earnings report?

The next expected earnings date for Third Harmonic Bio is 26 March 2025